Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOPOTECAN for Sarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where TOPOTECAN was used for Sarcoma.

Most Reported Side Effects for TOPOTECAN

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 425 12.0% 21 330
Off label use 390 11.0% 88 72
Death 332 9.4% 331 17
Product use in unapproved indication 323 9.1% 36 40
Neutropenia 255 7.2% 34 147
Pyrexia 252 7.1% 23 222
Anaemia 242 6.8% 35 125
Malignant neoplasm progression 238 6.7% 61 26
Drug ineffective 216 6.1% 56 30
Disease progression 207 5.9% 77 30
Thrombocytopenia 207 5.9% 39 79
Vomiting 206 5.8% 16 135
Pancytopenia 177 5.0% 32 99
Diarrhoea 168 4.8% 13 111
Nausea 163 4.6% 19 70

Other Indications for TOPOTECAN

Neuroblastoma (443) Product used for unknown indication (350) Retinoblastoma (302) Lung neoplasm malignant (177) Small cell lung cancer (158) Ovarian cancer (155) Refractory cancer (141) Recurrent cancer (114) Neoplasm malignant (86) Congenital retinoblastoma (83)

Other Drugs Used for Sarcoma

DOXORUBICIN (409) PAZOPANIB (296) IFOSFAMIDE (280) EPIRUBICIN (132) NIVOLUMAB (124) VINCRISTINE (105) CYCLOPHOSPHAMIDE (79) ETOPOSIDE (75) TRABECTEDIN (75) TRONOXAL INYECTABLE (74)

Related Pages

TOPOTECAN Full Profile All Sarcoma Drugs TOPOTECAN Demographics TOPOTECAN Timeline